Medvantx’s Post

2 Years at MEDDICC? Completed it, mate! ✅ When I first stepped into MEDDICC, I was completely green to the SaaS and Sales industry... and I'd never heard of MEDDIC nor Andy Whyte (I know, sacrilegious admissions) 💀 Fast forward to 4th Jan 2024, and not only is my brain full of 239429349 new acronyms that I've learnt, but I'm also pleased to say that I actually understand MEDDPICC and how different members of the GTM can use it as a common language. In these two years, I've packed more into my career than ever before. Start-up life? It's like dog years – everything moves at warp speed. I started as a Marketing Manager and catapulted up the ranks to CMO.. which I'll always be eternally grateful for (especially after getting to go to SF late last year to participate in a CMO bootcamp!) Reflecting on the journey, we've re-branded, built a spanking new website, assembled a super Media team, launched a network of soon-to-be 10 shows, hosted the world's first MEDDIC conference, unleashed MEDDICC Operating System (our SaaS product) into the world... oh and I've been shortlisted for an award! And that's just the tip of the iceberg! It's hard to put into words how much I've learned in these two years, but one thing's for sure – I've been pushed way outside my comfort zone. Why? Because that's where the magic happens. It's where I'm challenged, where I grow, and definitely not where I stay stagnant. But, it's not all been sunshine and rainbows... of course there's been days of self-doubt, imposter syndrome, days when I questioned, "Can I do this?" But I'm beginning to realise now that those thoughts are a sign of strength... Given the whirlwind of achievements in just two years, I'm incredibly excited to see where the next two will take us. P.S The image below encapsulates my mood for 2024, thank u ppl! #WorkAnniversary #TwoYearsStrong #ChallengeAccepted

🔥 Not All MEDDIC is Equal: Here's Why! 🔥 We recently delved into two enlightening polls, and the results may intrigue you! At MEDDICC, we hold that the cornerstone of robust MEDDPICC adoption is weaving a common language through your teams (not just confined to sales, but embracing your entire GTM squad!) - yet a puzzle persists: How can we expect teams to share a common language when their past MEDDIC learning experience differs? We’ve even seen it in our own encounters with MEDDIC! For many of us, our knowledge and understanding of MEDDIC didn’t come with that first encounter, but with conscious application and use of it as a framework! From blogs to books to courses, comprehension and depth of understanding varies incredibly! Take Andy Whyte and Pim Roelofsen for example, for them, even though they had heard of MEDDIC, doesn't mean they were originally actually applying it or finding any success with it, only when they really dove into the world of MEDDICC did they start seeing the results! This is precisely why we stand firm that Not all MEDDIC is Equal! #MEDDIC #Poll #PollResults #commonlanguage #sales #GTMsquad #learningexperience 

From dream to reality: our Explorer, Rhandz, shares his journey to the U.S. 🌟 It wasn't easy, but with MedPro International by his side, he made it happen. Grateful for the unwavering support every step of the way! ✨ Ready to make your dream a reality? Apply today and start your own adventure! Link in Bio #MedProInternational #DreamsComeTrue #ApplyToday

Well, Ashley McEvoy is as close as you can come to being a #medtech CEO without holding the title, so this DeviceTalks West interview I did a few months ago with Joe Mullings of the The Mullings Group was particularly interesting. At 1:12 he offers the following, "I think you’re going to see another major move on a CEO in the next six months in #medtech, and it will be one of the Top 5s.". We'll see if more moves are coming. #medicaldevices #medicaldevice #dtwest2023 #Joestradamus

Embracing the ethos of perseverance at StarClinch! 😄 In our journey, we recognize that perfection is subjective. It's about striving for excellence, learning from mistakes, and relentlessly moving forward. Let's keep pushing boundaries and evolving together! #Perseverance #ContinuousImprovement #StarClinchJourney 

We love this throwback to the first ever MEDMEN episode with Andy Whyte and Pim Roelofsen, it was just over two years ago that we started to cement our belief that MEDDIC is best applied as a common language. Fast forward to now, its no longer a belief but more a proven fact that for organizations to improve efficiencies and revenue output, having a common language is crucial. Pretty cool to reflect on the journey of MEDMEN and MEDDICC. Watch the full episode using the link in the comments. #MEDDIC #MEDDPICC #MEDDICC #MEDMEN #DealReviews

🏆 Three weeks post-Protocol Bowl, and we're still riding the victory wave! 🏆 Team Digital's triumph over Team Paper wasn't just a win; it was a seismic shift in the clinical trials game!💥💻 Say goodbye to footnotes and confusion; with ProofPilot's digital platform, it's all about speed, precision, and confidence. 🚀💪 Don't get left in the paper trail - join the digital revolution today! #clinicaltrials #clinicalresearch #clinicaloperations #scope2024 #scopesummit2024

Exciting News: ALTERTOX and DCL solutions Partner Up for NAMs and 3Rs Advancement! We're thrilled to announce a powerful new partnership between @Altertox and @DCL solutions! This collaboration brings together industry leaders with a shared mission: to transform how we tackle New Alternative Methods (#NAMs) and advance the principles of #3Rs (#Replacement, #Reduction, and #Refinement) in science. Through this partnership, we'll be exploring innovative solutions to: · Accelerate the adoption of NAMs: We'll work together to make NAMs more accessible and user-friendly for scientists worldwide. · Drive impactful advancements in the 3Rs: By leveraging our combined expertise, we'll develop new strategies to reduce and refine animal testing while maintaining scientific rigor. · Set a dialogue across all stakeholders: Comprehensive assessment of scientific approaches will foster the acceptance of new models and new mindset.  Stay tuned for more exciting developments as this #partnership unfolds! We're committed to making a positive impact on the future of scientific research. Let us know in the comments below what you're most excited about with this collaboration!   #NAMs #3Rs #Science #Partnership #Altertox #DCLSolutions #Innovation    

If your 2024 clinical trial strategy doesn’t include DCT, why not? Come hear my colleague Wes Fishburne talk about how Zelta can help you with DCT and eConsent.

At Medrio, we recognize the significant impact of delays on timelines in #ClinicalResearch. Don’t let technology be a reason you miss study milestones. Our #ePRO builds are completed 50% faster compared to other major solutions providers. Let us help get your study up and running and on the way to FPI faster ⏳ https://bit.ly/3s34GvT